ACT Lung Health Intervention: Phase Two
Description
This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance.
The research study procedures include screening for eligibility, questionnaires, and saliva tests.
It is expected participation in this study will last about 6 months.
About 60 participants are expected to take part in this research study.
The National Cancer Institute is providing funding for this trial.
Our expert team has 10+ years running successful recruitment campaigns for clinical research sites